Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

March 31, 2018

Conditions

Cerebrovascular Diseases

Interventions

DRUG

Yangxue Qingnao pill

The treatment group (20 cases) was treated with Yangxue Qingnao pill (2.5g / time, 3 times / day, orally for 6 months

DRUG

Hydergotoxine mesylate tablets

The control group (n = 20) was treated with hidezhen 3 mg per day before meals for 6 months

OTHER

blank control group

There were 20 cases in the blank control group.Outpatient consultation at any time was prescribed.

Trial Locations (1)

Peking University Third Hospital, Beijing

All Listed Sponsors

collaborator

Beijing Hospital

OTHER_GOV

lead

Peking University Third Hospital

OTHER

NCT04958512 - Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill | Biotech Hunter | Biotech Hunter